Trial intelligence / Profile preview

Etanercept Mouthwash for Chemotherapy-Related Stomatitis

NCT00031551Phase 2Terminated

Sponsor
National Institute of Nursing Research
Start
Mar 2002
Primary completion
Aug 2010
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in stomatitis comparing Etanercept Mouthwash with Placebo Mouthwash (2 arms). Primary endpoint: Clinical Efficacy of Etanercept Mouthwash at 2 years. Started Mar 2002; status: terminated.

02

Drugs

etanercept
03

Conditions

stomatitis

Beyond the preview

Go deeper on NCT00031551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00031551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call